Further supporting evidence for a role for DNA activation in MPO-ANCA GN comes from the capacity for DNA subcomponents (e.g., CpG, bacterial DNA components) alone to provide sufficient adjuvant support to allow MPO immunization to induce anti-MPO autoimmunity and GN (24, 55). This evidence concerns the gene MPO and ganglioneuroma.